Education
Degree: PhD
Year: 2003
Institution: University of Toronto, Dept. of Laboratory Medicine and Pathobiology, Faculty of Medicine
Discipline: Clinical Biochemistry
Degree: M.Sc.
Year: 1997
Institution: National and Kapodistrian University of Athens, Dept. of Chemistry
Discipline: Clinical Chemistry
Degree: B.S.
Year: 1994
Institution: : National and Kapodistrian University of Athens
Discipline: Biology
Angeliki Magklara
Department of Medicine
Contact Information
Tel.: +30-26510 07818e-mail: Personal/Dept/Lab URL/: https://www.imbb.forth.gr/imbb-people/index.php/en/magklara-laboratory
Research topics (related to the Institute)
- Study of epigenetic regulation of breast cancer stem cells.
- Epigenetic tumor heterogeneity as a contributing factor of chemoresistance in breast cancer.
- Evaluation of bioactive natural compounds in breast cancer.
Research summary
- Dr. Magklara’s research interests focus on the study of breast tumor epigenetic heterogeneity as a mechanism of chemoresistance. Currently, the team efforts focus on the development of in vitro models (e.g. chemoresistant cell lines and 3D spheroids enriched in cancer stem cells) with the main goal being the identification of novel therapeutic epigenetic targets to overcome drug-resistance.
Professional background
| 2.2021 - present | Associate Professor, Dept. of Medicine, UoI |
| 9.2015 - 2.2021 | Assistant Professor, Dept. of Medicine, UoI |
| 10.2018-3.2019 | Fulbright Visiting Scholar, Whitehead Institute for Biomedical Research, MIT, Cambridge, MA, USA |
| 1.2014 - 9.2015 | Lecturer Dept. of Medicine, UoI |
| 9.2012 - σήμερα | Group leader at IMBB-FORTH-Dept. of Biomedical Research, Ioannina |
| 1.2008 - 8.2012 | Post-doctoral Research Associate, University of California San Francisco (UCSF), San Francisco, CA USA. |
| 4.2003-12.2007 | Post-doctoral Visiting Fellow, National Cancer Institute (NCI/NIH), Bethesda, MD, USA. |